{"gene":"CCR7","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1997,"finding":"CCL19 (ELC) was identified as a specific, high-affinity functional ligand for CCR7 (EBI1): recombinant ELC-alkaline phosphatase fusion protein bound specifically to CCR7-transfected cells, and ELC induced calcium mobilization and chemotaxis exclusively through CCR7 among five CC chemokine receptors and five orphan receptors tested.","method":"Receptor-binding assay with alkaline phosphatase-fused ligand, calcium mobilization assay, chemotaxis assay in stably transfected cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal in vitro assays (binding, calcium flux, chemotaxis) with specificity controls across multiple receptors","pmids":["9153236"],"is_preprint":false},{"year":1998,"finding":"CCR7-mediated chemotaxis in lymphocytes is coupled to a Gαi protein, as demonstrated by complete blockade with pertussis toxin; CCL19 (CK beta-11/MIP-3β/ELC) induced actin polymerization and calcium mobilization in T and B cells via CCR7.","method":"Chemotaxis assay with pertussis toxin inhibition, actin polymerization assay, calcium mobilization assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — pertussis toxin inhibition directly demonstrates Gαi coupling; multiple orthogonal functional assays","pmids":["9498785"],"is_preprint":false},{"year":1995,"finding":"CCR7 (BLR2/EBI1) gene transcription is specifically induced by Epstein-Barr virus nuclear antigen 2 (EBNA2) in B cells, identifying EBNA2 as a transcriptional activator of CCR7.","method":"Northern blot, estrogen-inducible EBNA2 activation system in EBV-negative BL41 cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — direct transcriptional induction shown by Northern blot with inducible EBNA2 system, single lab","pmids":["7488016"],"is_preprint":false},{"year":2001,"finding":"CCL19 (ELC) and CCL21 (SLC) differ fundamentally in their ability to induce CCR7 internalization: CCL19 rapidly induces CCR7 internalization and receptor desensitization in a time- and concentration-dependent manner, whereas CCL21 does not trigger internalization, allowing persistent CCR7 surface expression and continued responsiveness.","method":"Flow cytometry-based receptor redistribution assay, functional desensitization assay in CCR7-bearing T lymphocytes","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — direct receptor internalization measured by flow cytometry with functional desensitization readout; clear differential between two ligands","pmids":["11745346"],"is_preprint":false},{"year":2002,"finding":"CCR7 mediates lymphocyte homing to peripheral lymph nodes through a JAK tyrosine kinase-dependent pathway: the JAK inhibitor Tyrphostin AG490 blocked CCR7-mediated chemotaxis and CCL21-induced α4/β2 integrin upregulation, and CCL21 stimulation induced rapid Jak2 phosphorylation in primary mouse lymphocytes; in vivo, AG490-treated lymphocytes showed significantly reduced adhesion in high endothelial venules.","method":"Pharmacological inhibition (Tyrphostin AG490), static and flow adhesion assays, intravital microscopy, Jak2 phosphorylation by western blot","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (in vitro chemotaxis, adhesion assays, in vivo intravital microscopy, biochemical phosphorylation); single lab but comprehensive","pmids":["12393730"],"is_preprint":false},{"year":2003,"finding":"CCR7-mediated T lymphocyte polarization and chemotaxis require Rho kinase: inhibition of Rho kinase isoforms with Y-27632 strongly blocked CCL19- and CCL21-induced polarized morphology and chemotaxis, whereas blockade of ERK2 had no effect on these processes.","method":"Pharmacological inhibition (Y-27632 for Rho kinase; ERK inhibitor), T lymphocyte chemotaxis and polarization assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological inhibition with clear functional readouts; single lab","pmids":["12729902"],"is_preprint":false},{"year":2004,"finding":"CCR7 is essential for dendritic cell entry into dermal lymphatic vessels and for DC migration to skin-draining lymph nodes under both inflammatory and steady-state conditions; CCR7-deficient mice lacked a population of semimature tolerogenic DCs in skin-draining lymph nodes.","method":"CCR7 knockout mouse model, flow cytometry, immunohistology, DC trafficking assays","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with defined cellular phenotype replicated across inflammatory and steady-state conditions; highly cited foundational paper","pmids":["15308107"],"is_preprint":false},{"year":2004,"finding":"CCR7 signaling regulates the migration of early T cell progenitors from the cortico-medullary junction toward the outer thymic cortex; CCR7-deficient mice show disturbed thymic architecture, impaired T cell development, and accumulation of CD25+CD44+ cells at the cortico-medullary junction.","method":"CCR7 knockout mouse model, immunohistology, mixed bone marrow chimeras, flow cytometry","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with mechanistic localization data and mixed chimera confirmation; single lab but multiple orthogonal methods","pmids":["15302903"],"is_preprint":false},{"year":2007,"finding":"CCR7 signaling inhibits T cell proliferation and IL-2 secretion: sustained engagement of CCR7 by high concentrations of soluble or immobilized CCL19/CCL21 induces cell cycle arrest associated with delayed degradation of the CDK inhibitor p27Kip1 and downregulation of CDK1; CCR7 knockout T cells show increased proliferative responses, confirming receptor specificity.","method":"T cell proliferation assays with soluble/immobilized ligand, CCR7 KO comparison, western blot for p27Kip1 and CDK1","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — KO rescue controls, biochemical mechanism (p27Kip1/CDK1), multiple conditions; single lab","pmids":["17982037"],"is_preprint":false},{"year":2008,"finding":"CCR7 in vivo surface expression and occupancy are dynamically modulated by its ligands: in secondary lymphoid organs (but not blood), most T cell CCR7 is occupied by CCL19, leading to continuous signaling and reduced ligand sensitivity; both ligands trigger CCR7 internalization in vivo as shown in Ccl19-deficient and plt/plt mice.","method":"In vivo CCR7 occupancy analysis, Ccl19-/- and plt/plt mice, in vitro internalization assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic models (KO mice) with in vivo and in vitro orthogonal assays","pmids":["19017956"],"is_preprint":false},{"year":2009,"finding":"CCR7 expression in T-ALL is transcriptionally controlled by the Notch1 oncogene; CCR7 (and its ligand CCL19) is the essential signal required for leukaemic T-cell infiltration of the CNS—silencing either CCR7 or CCL19 specifically inhibits CNS infiltration in a mouse T-ALL model.","method":"Gene expression profiling, T-ALL animal modeling, CCR7/CCL19 silencing (genetic), xenograft with human T-ALL cells","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis (Notch1 → CCR7) with in vivo silencing; multiple animal models including human xenograft","pmids":["19536265"],"is_preprint":false},{"year":2009,"finding":"CCR7 controls lymphocyte egress from body cavities: CCR7 deficiency causes massive accumulation of CD4+, CD8+ T cells and B-2 B cells in the peritoneal and pleural cavities due to impaired CCR7-dependent lymphocyte exit, not altered maturation status.","method":"CCR7 knockout mouse model, flow cytometry of peritoneal/pleural lavage cells, lymphocyte recirculation assays","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with specific cellular phenotype; single lab","pmids":["20028772"],"is_preprint":false},{"year":2010,"finding":"The actin-bundling protein L-plastin (LPL) is required for CCR7-mediated T cell motility: LPL-deficient T cells fail to polarize CCR7 to the leading edge upon CCR7 ligation, resulting in defective chemotaxis and reduced thymic egress in vivo; however, CCR7 signaling to F-actin polymerization and CCR7-mediated costimulation remain intact in LPL-/- cells.","method":"LPL knockout mice, two-photon microscopy of lymph nodes, intravital migration assays, receptor localization imaging, thymic egress assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with in vivo (two-photon) and in vitro dissection of signaling vs. motility; multiple orthogonal methods","pmids":["20194718"],"is_preprint":false},{"year":2012,"finding":"CCR7/CCL19 signaling upregulates EDG-1 (S1P1) expression in T cells via an ERK5–KLF-2 signaling axis: CCL19 stimulation induces ERK5 phosphorylation and increased expression of the transcription factor KLF-2 and subsequently EDG-1, which mediates T cell egress from lymph nodes; ERK5 deletion in T cells (Lck-Cre) abolishes this CCL19-induced EDG-1 upregulation.","method":"T cell stimulation assays, ERK5-flox/Lck-Cre conditional KO mice, migration assays to S1P ligands, western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic conditional KO with pathway mechanistic follow-up (ERK5→KLF-2→EDG-1); multiple orthogonal methods","pmids":["22334704"],"is_preprint":false},{"year":2014,"finding":"CCR7 uses distinct, largely independent signaling modules in dendritic cells with biased functionality: PI3K/Akt controls DC survival, the MAPK pathway controls chemotaxis, and the RhoA pathway controls actin dynamics, migratory speed, cytoarchitecture, and endocytosis.","method":"Pharmacological inhibition of individual signaling pathways, DC functional assays (survival, chemotaxis, speed, endocytosis), biochemical pathway analysis","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple pharmacological inhibitors dissecting signaling modules; single lab","pmids":["32351499"],"is_preprint":false},{"year":2015,"finding":"CCR7 is N-glycosylated at two specific residues in the N-terminus and third extracellular loop; glycosylation (particularly sialylation) dampens CCR7 signaling and receptor endocytosis, thereby restraining chemotactic responses. Dendritic cells boost T cell migration by secreting deglycosylating enzymes that remove sialylation from CCR7 on T cells, and also proteolytically convert immobilized CCL21 to a soluble form with distinct signaling properties.","method":"Mutagenesis of glycosylation sites, enzymatic deglycosylation, flow cytometry, migration assays, receptor endocytosis assays; metabolic glycan labeling","journal":"Journal of leukocyte biology","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis of specific sites combined with enzymatic deglycosylation and multiple functional readouts; mechanistically comprehensive","pmids":["26819318"],"is_preprint":false},{"year":2015,"finding":"CCL19 NMR solution structure reveals a canonical chemokine fold; chemical shift mapping shows that the N-termini of PSGL-1 and CCR7 have overlapping, competitive binding sites for CCL19, providing a structural basis for PSGL-1 enhancement of T cell recruitment.","method":"NMR solution structure determination, chemical shift perturbation mapping, competitive binding assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with functional binding site mapping; competitive assay validation","pmids":["26115234"],"is_preprint":false},{"year":2015,"finding":"CCR7 expression on breast cancer cells promotes tumor lymphangiogenesis via VEGF-C secretion through the AKT signaling pathway: CCR7-mediated AKT activation drives VEGF-C secretion, which promotes lymphatic endothelial cell proliferation, migration, and tube formation.","method":"CCR7/CCL21 gene-manipulated orthotopic xenograft mouse model, in vitro lymphangiogenesis assays (proliferation, migration, tube formation), AKT inhibition, ELISA","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo and in vitro with pathway inhibition; single lab","pmids":["25744065"],"is_preprint":false},{"year":2017,"finding":"CCR7 homodimerization directly regulates CCR7-dependent cell migration and signaling: induction of stable CCR7 homodimers enhanced cell migration and CCL19 binding, while a novel CCR7-derived synthetic peptide that disrupted homodimerization attenuated CCR7-dependent migration, ligand-induced internalization, actin rearrangement, and Akt/Erk signaling.","method":"CCR7 homodimer induction/disruption (synthetic peptide), CXCR4/CCR7 heterodimerization experiments, migration assays, ligand-binding assays, internalization assays, signaling (Akt/Erk) western blot","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — bidirectional manipulation (induction and disruption) of dimerization with multiple orthogonal functional and biochemical readouts","pmids":["28819198"],"is_preprint":false},{"year":2018,"finding":"Glycolytic metabolism is required for CCR7 oligomerization and DC migration to draining lymph nodes: early glycolysis induction (via AKT, TBK, mTOR activation) supports elongated DC morphology, CCR7 oligomerization on the cell surface, and DC motility; inhibiting glycolysis impairs these functions regardless of mitochondrial bioenergetics.","method":"Glycolysis inhibition (2-DG), AKT/TBK/mTOR pathway analysis, CCR7 oligomerization assays, DC motility assays, in vivo DC migration to lymph nodes","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — pharmacological and genetic inhibition with mechanistic link to CCR7 oligomerization; multiple orthogonal methods in vitro and in vivo","pmids":["29941886"],"is_preprint":false},{"year":2019,"finding":"CCR7 stimulation activates the HIF-1α transcription factor pathway in DCs, inducing metabolic reprogramming toward glycolysis to fuel DC migration; CCR7 stimulation also upregulates the lncRNA lnc-Dpf3 by removing m6A methylation to prevent RNA degradation. lnc-Dpf3 then directly binds HIF-1α and suppresses HIF-1α-dependent transcription of the glycolytic gene Ldha, creating a negative feedback loop that restrains CCR7-mediated DC migration.","method":"DC-specific lnc-Dpf3 knockout, RNA pull-down/RIP for lnc-Dpf3:HIF-1α interaction, m6A modification analysis, metabolic (glycolysis) assays, in vivo DC migration assays, inflammatory disease models","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1-2 — cell-specific KO, direct molecular interaction (lnc-Dpf3:HIF-1α), mechanistic pathway with m6A epigenetic regulation; multiple orthogonal methods","pmids":["30824325"],"is_preprint":false},{"year":2019,"finding":"CCR7 signals from endomembrane compartments to sustain directed DC migration: upon CCL19 binding, β-arrestin and Src kinase are co-trafficked with internalized CCR7 to endosomes; Src tyrosine-phosphorylates CCR7 at endomembranes, recruiting Vav1 (a RhoGEF) and Rac1 to form a multi-protein signaling complex; photoactivation of Rac1 at endomembranes drives lamellipodia formation at the leading edge.","method":"Co-immunoprecipitation, proximity ligation assay, vesicular trafficking inhibition, Src kinase mutagenesis, Rac1 photoactivation, live-cell imaging","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including mutagenesis, protein interaction assays, and spatially resolved Rac1 photoactivation; mechanistically comprehensive","pmids":["31644919"],"is_preprint":false},{"year":2020,"finding":"CCL21/CCR7 axis promotes EMT and cancer stemness in OSCC via JAK2/STAT3 pathway: CCL21 stimulation markedly increased phospho-JAK2 and phospho-STAT3; JAK2/STAT3 inhibition suppressed CCL21-induced EMT and stemness markers; CCR7 knockdown blocked these effects.","method":"CCR7 knockdown/overexpression, JAK2/STAT3 inhibitor treatment, western blot for EMT and stemness markers, migration/invasion/tumorsphere assays","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KD and pharmacological inhibition with multiple functional readouts; single lab","pmids":["32017846"],"is_preprint":false},{"year":2021,"finding":"At CCR7, CCL19 and CCL21 both stimulate G protein signaling and β-arrestin recruitment, with CCL19 consistently displaying higher potency; this systematic comparison in the same cellular background reveals CCR7's intrinsic coupling capabilities without evidence of ligand-biased agonism between CCL19 and CCL21.","method":"Systematic BRET-based G protein activation and β-arrestin recruitment assays in a uniform cellular background","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1 — systematic in vitro signaling assays in defined cellular system; single study","pmids":["33921794"],"is_preprint":false},{"year":2022,"finding":"Neutrophils upregulate CCR7 in response to microbial stimuli and migrate from inflamed skin to draining lymph nodes via lymphatic vessels in a CCR7-dependent manner; in the lymph nodes, these neutrophils are phagocytosed by resident cDC1 and cDC2, and CCR7-deficient neutrophils show increased antistaphylococcal immunity and aggravated skin inflammation.","method":"Selective CCR7 deficiency on neutrophils (bone marrow chimeras), photoconvertible mouse tracking, mouse models of TLR-induced skin inflammation and S. aureus infection, flow cytometry","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO with in vivo trafficking and functional consequences; multiple disease models","pmids":["35119939"],"is_preprint":false},{"year":2022,"finding":"ACKR4 (atypical chemokine receptor 4) expressed on lymphatic collector endothelium acts as a flow-induced scavenger of CCL19 and CCL21, enabling T cell detachment from the vessel wall and transition to free-flow transport toward draining lymph nodes; loss of ACKR4 causes T cell accumulation in dermal collecting vessel segments.","method":"ACKR4-deficient mice, flow-induced gene expression analysis, T cell trafficking assays in TPA-induced inflammation, intravital microscopy","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with precise in vivo trafficking readout and mechanistic link to CCR7 ligand scavenging","pmids":["35108538"],"is_preprint":false},{"year":2023,"finding":"CCR7 acts as both a sensor and a sink for CCL19: upon CCL19 binding, DCs internalize CCR7 together with CCL19 as part of canonical GPCR desensitization, which depletes the local chemokine and dynamically reshapes the chemotactic gradient. This self-generated gradient mechanism drives collective DC migration, enables long-range guidance, and allows DCs to guide comigrating cells.","method":"Experimental chemotaxis assays combined with mathematical modeling, CCR7 internalization tracking, chemokine gradient visualization, collective migration assays","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 — integration of experimental data with quantitative theory; multiple orthogonal experimental validations of gradient-shaping mechanism","pmids":["37656776"],"is_preprint":false},{"year":2014,"finding":"Epigenetic silencing of the Ccr7 locus by H3K27me3 (trimethylation of histone 3 lysine 27) controls differential CCR7 expression between conventional DCs and monocyte-derived DCs in the lung, and this epigenetic modification is acquired gradually during monocyte-to-moDC differentiation rather than at early lineage commitment.","method":"ChIP-seq/ChIP-PCR for H3K27me3, comparison of bone marrow-derived and lung DC subsets, monocyte differentiation time-course","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP analysis at defined locus with developmental time-course; single lab","pmids":["25297875"],"is_preprint":false},{"year":2015,"finding":"FOXO1 directly binds the CCR7 promoter and stimulates CCR7 transcriptional activity in dendritic cells; FOXO1 nuclear localization is induced by bacteria through the MAPK pathway, and FOXO1-dependent CCR7 expression is required for DC chemotaxis and lymph node homing in vivo.","method":"ChIP assay for FOXO1 binding at CCR7 promoter, luciferase reporter assay, DC-specific FOXO1 KO (CD11c.Cre), ICAM-1/CCR7 rescue transfection, in vivo lymph node homing assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — direct promoter binding (ChIP), luciferase reporter, genetic KO with rescue; multiple orthogonal methods","pmids":["25786691"],"is_preprint":false},{"year":2013,"finding":"CCL19/CCR7 promotes invasion of lung cancer cells by upregulating heparanase via the transcription factor Sp1: CCL19 stimulation increased Sp1 and heparanase expression; CCR7 blockade suppressed Sp1 and heparanase; Sp1 inhibition downregulated heparanase; and ChIP demonstrated Sp1 binding to the heparanase promoter.","method":"CCR7 blocking antibody, Sp1 inhibition, ChIP for Sp1 binding to heparanase promoter, RT-PCR, western blot, cell invasion assay","journal":"Tumour biology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP provides direct promoter binding evidence; multiple inhibitor conditions; single lab","pmids":["23649655"],"is_preprint":false},{"year":2009,"finding":"JAK3 participates in CCR7-mediated DC migration: Jak3-/- bone marrow-derived DCs show impaired chemotactic responses to CCL19 and CCL21 in vitro and in vivo, reduced co-stimulatory molecule expression, and decreased ability to activate T lymphocytes.","method":"Jak3 knockout mice, in vitro and in vivo DC migration assays (CCL19/CCL21), contact hypersensitivity assay, lymphocyte proliferation assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with in vivo and in vitro functional readouts; single lab","pmids":["19759904"],"is_preprint":false},{"year":2023,"finding":"CCR7 activates PI3Kγ in ALCL tumor cells, providing a survival pathway that confers resistance to ALK tyrosine kinase inhibitors; endothelial cells producing CCL19/CCL21 protect ALCL cells from apoptosis in a CCR7-dependent manner, and genetic CCR7 deletion blocks CNS dissemination and perivascular growth of ALCL in TKI-treated mice.","method":"ALCL cell lines and patient-derived xenografts, 3D microfluidic chip with endothelial cells, CCR7 genetic deletion in mouse models, PI3Kγ/δ inhibitor (duvelisib), constitutively active PI3Kγ mouse model","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic KO and pharmacological inhibition, multiple in vivo and in vitro models, clinical patient data","pmids":["37379367"],"is_preprint":false},{"year":2018,"finding":"CCR7 signals through the PI3K/Akt pathway to support DC and cancer cell survival, through MAPK to control chemotaxis, and through RhoA to regulate actin dynamics; these pathways function as biased, largely independent modules for distinct cellular functions.","method":"Pathway-specific pharmacological inhibitors, DC functional assays (survival, chemotaxis, endocytosis, actin dynamics), biochemical signaling analysis","journal":"Frontiers in pharmacology (review synthesizing primary data)","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic data synthesized across multiple primary experiments; pathway dissection supported by pharmacological inhibitors","pmids":["35281921"],"is_preprint":false}],"current_model":"CCR7 is a Class A GPCR that couples to Gαi and signals through distinct biased modules—PI3K/Akt (survival), MAPK (chemotaxis), and RhoA/Rho kinase (actin dynamics and motility)—while its two ligands CCL19 and CCL21 elicit differential responses: CCL19 triggers rapid, strong but transient CCR7 internalization and desensitization via β-arrestin/Src endomembrane signaling (forming a Vav1–Rac1 complex that sustains directional migration), whereas CCL21 does not internalize the receptor, permitting persistent surface signaling; N-glycosylation/sialylation of two extracellular residues fine-tunes receptor sensitivity and endocytosis, FOXO1 and EBNA2 transcriptionally regulate CCR7 expression, H3K27me3 epigenetically silences the locus in monocyte-derived DCs, and CCR7 homodimerization enhances ligand binding and downstream Akt/Erk signaling—collectively orchestrating the homing of naïve T cells, regulatory T cells, and dendritic cells to secondary lymphoid organs while also enabling CCR7-expressing cancer cells to metastasize to lymph nodes via CCL19/CCL21 gradients."},"narrative":{"teleology":[{"year":1995,"claim":"Before any ligand was known, EBNA2 was shown to transcriptionally activate the orphan receptor EBI1 (later CCR7) in B cells, establishing the gene as an EBV-responsive locus even before its chemokine receptor identity was understood.","evidence":"Northern blot with estrogen-inducible EBNA2 system in EBV-negative BL41 B cells","pmids":["7488016"],"confidence":"Medium","gaps":["single inducible system without chromatin-level analysis","no demonstration of direct EBNA2 binding to the CCR7 promoter","functional consequence of EBNA2-induced CCR7 on B cell biology not tested"]},{"year":1997,"claim":"The identification of CCL19 as a specific high-affinity ligand for CCR7 deorphanized the receptor and established it as a functional chemokine receptor capable of triggering calcium flux and chemotaxis.","evidence":"Alkaline phosphatase-fused ligand binding, calcium mobilization, and chemotaxis assays across multiple transfected receptor lines","pmids":["9153236"],"confidence":"High","gaps":["CCL21 not yet identified as a second ligand","G protein coupling not characterized"]},{"year":1998,"claim":"Pertussis toxin sensitivity demonstrated that CCR7 signals through Gαi, and CCL19 was shown to induce actin polymerization in primary lymphocytes, linking the receptor to cytoskeletal remodeling.","evidence":"Pertussis toxin blockade of chemotaxis, actin polymerization and calcium assays in primary T and B cells","pmids":["9498785"],"confidence":"High","gaps":["downstream effectors between Gαi and actin not identified","relative contribution of Gαi vs. Gβγ not resolved"]},{"year":2001,"claim":"The discovery that CCL19 but not CCL21 triggers CCR7 internalization and desensitization revealed a fundamental asymmetry between the two ligands, raising the question of how the same receptor produces distinct cellular outcomes depending on which ligand it engages.","evidence":"Flow cytometry-based internalization and functional desensitization assays in T lymphocytes","pmids":["11745346"],"confidence":"High","gaps":["molecular basis for differential internalization (β-arrestin recruitment difference) not yet determined","in vivo significance of differential desensitization unknown"]},{"year":2002,"claim":"JAK2 phosphorylation downstream of CCR7 and inhibition of chemotaxis/integrin activation by JAK inhibitor AG490 revealed a JAK-dependent signaling arm linking CCR7 to lymphocyte adhesion in high endothelial venules in vivo.","evidence":"AG490 treatment, intravital microscopy of HEV adhesion, JAK2 phosphorylation western blot in primary lymphocytes","pmids":["12393730"],"confidence":"High","gaps":["which JAK isoform is essential (JAK2 vs. JAK3) not fully resolved","direct physical JAK–CCR7 interaction not shown"]},{"year":2003,"claim":"Rho kinase was identified as required for CCR7-mediated T cell polarization and chemotaxis, while ERK was dispensable, beginning to dissect signal-specific pathway modules downstream of the receptor.","evidence":"Y-27632 (Rho kinase inhibitor) blockade of CCL19/CCL21-induced polarization and migration in T cells","pmids":["12729902"],"confidence":"Medium","gaps":["pharmacological inhibitor specificity concerns","upstream RhoA activation by CCR7 not directly shown","RhoGEF identity unknown"]},{"year":2004,"claim":"CCR7 knockout mice revealed non-redundant in vivo roles: CCR7 is essential for DC entry into lymphatics and migration to draining lymph nodes, and separately for intrathymic migration of T cell progenitors, establishing CCR7 as a master regulator of immune cell positioning across tissues.","evidence":"CCR7-/- mice with flow cytometry, immunohistology, DC trafficking assays, and mixed bone marrow chimeras","pmids":["15308107","15302903"],"confidence":"High","gaps":["relative contribution of CCL19 vs. CCL21 in each tissue not resolved","compensatory mechanisms in chronic KO not excluded"]},{"year":2007,"claim":"Beyond migration, CCR7 engagement was found to inhibit T cell proliferation and IL-2 secretion via delayed p27Kip1 degradation and CDK1 downregulation, revealing an unexpected anti-proliferative signaling function verified by CCR7-KO T cell hyperproliferation.","evidence":"Proliferation assays with soluble/immobilized CCL19/CCL21, CCR7-KO comparison, p27Kip1 and CDK1 western blots","pmids":["17982037"],"confidence":"High","gaps":["pathway connecting Gαi to p27Kip1 stabilization not identified","physiological relevance of anti-proliferative signaling in SLOs not tested in vivo"]},{"year":2008,"claim":"In vivo occupancy studies showed that most surface CCR7 on T cells in secondary lymphoid organs is constitutively engaged by CCL19, explaining why transferred T cells have reduced chemokine sensitivity in lymph nodes and demonstrating continuous physiological CCR7 signaling.","evidence":"CCR7 occupancy analysis in Ccl19-/- and plt/plt mice with in vitro internalization validation","pmids":["19017956"],"confidence":"High","gaps":["how continuous engagement affects T cell function beyond desensitization not fully explored","occupancy by CCL21 in vivo not quantified"]},{"year":2009,"claim":"Notch1 was identified as a transcriptional driver of CCR7 in T-ALL, and CCR7/CCL19 signaling was shown to be specifically required for leukemic T cell infiltration of the CNS, linking CCR7 to pathological tissue invasion.","evidence":"Gene expression profiling, genetic silencing of CCR7/CCL19 in mouse T-ALL models and human xenografts","pmids":["19536265"],"confidence":"High","gaps":["whether pharmacological CCR7 blockade is therapeutically viable in CNS leukemia not tested","downstream signaling pathway mediating CNS entry not identified"]},{"year":2009,"claim":"CCR7 was found to control lymphocyte egress from body cavities—not just entry into lymph nodes—as CCR7-deficient mice accumulated T and B cells in peritoneal and pleural spaces, broadening the receptor's role to general lymphocyte recirculation.","evidence":"CCR7-KO mice, flow cytometry of peritoneal/pleural lavage, lymphocyte recirculation assays","pmids":["20028772"],"confidence":"Medium","gaps":["which ligand (CCL19 or CCL21) mediates cavity egress unknown","mechanism of CCR7-dependent egress from serosal surfaces not dissected"]},{"year":2010,"claim":"L-plastin was identified as required for CCR7 polarization to the leading edge and T cell chemotaxis, but dispensable for CCR7-triggered F-actin polymerization, separating receptor signaling from spatial receptor redistribution during migration.","evidence":"LPL-/- mice, two-photon microscopy in lymph nodes, receptor localization imaging, thymic egress assays","pmids":["20194718"],"confidence":"High","gaps":["direct LPL–CCR7 physical interaction not demonstrated","mechanism linking LPL to CCR7 membrane clustering unknown"]},{"year":2012,"claim":"CCR7/CCL19 was found to upregulate S1P receptor 1 (S1P1) expression via an ERK5→KLF-2 axis, revealing a cross-talk mechanism whereby CCR7 primes T cells for subsequent S1P1-dependent lymph node egress.","evidence":"ERK5-flox/Lck-Cre conditional KO, migration assays to S1P, western blot for pathway components","pmids":["22334704"],"confidence":"High","gaps":["whether CCL21 activates the same ERK5–KLF-2 axis not tested","in vivo validation of CCR7-dependent S1P1 upregulation for LN egress not shown"]},{"year":2014,"claim":"Epigenetic profiling revealed that H3K27me3 silences the Ccr7 locus specifically in monocyte-derived DCs but not conventional DCs, explaining lineage-specific CCR7 expression and migratory capacity differences between DC subsets.","evidence":"ChIP-seq/ChIP-PCR for H3K27me3 in bone marrow-derived and lung DC subsets, monocyte differentiation time-course","pmids":["25297875"],"confidence":"Medium","gaps":["identity of the histone methyltransferase responsible not determined","whether H3K27me3 removal can rescue moDC migration not tested"]},{"year":2015,"claim":"Multiple advances refined CCR7 regulation: FOXO1 was shown to directly bind and activate the CCR7 promoter in DCs (controlling in vivo LN homing), N-glycosylation/sialylation of two extracellular residues was found to dampen CCR7 signaling and endocytosis, and NMR mapping revealed overlapping CCR7/PSGL-1 binding sites on CCL19.","evidence":"ChIP and luciferase reporter for FOXO1, DC-specific FOXO1-KO with rescue; mutagenesis of glycosylation sites with functional assays; NMR structure of CCL19 with chemical shift perturbation","pmids":["25786691","26819318","26115234"],"confidence":"High","gaps":["whether FOXO1 and epigenetic (H3K27me3) regulation are coordinated is unknown","structural basis of glycosylation effects on receptor conformation not resolved","functional consequence of PSGL-1/CCR7 competition for CCL19 in vivo not tested"]},{"year":2017,"claim":"CCR7 homodimerization was shown to enhance ligand binding, migration, and Akt/Erk signaling, as demonstrated by a synthetic peptide that disrupted dimers and attenuated all CCR7 functions, establishing oligomeric state as a regulatory mechanism.","evidence":"Bidirectional dimer induction/disruption with synthetic peptide, migration, binding, internalization, and signaling assays","pmids":["28819198"],"confidence":"High","gaps":["structural basis of CCR7 dimer interface not determined","stoichiometry of active signaling complex unknown","in vivo relevance of dimerization not tested"]},{"year":2018,"claim":"Glycolytic metabolism was linked to CCR7 function: early glycolysis induction supports CCR7 oligomerization and DC motility, and PI3K/Akt, MAPK, and RhoA were confirmed as biased, largely independent signaling modules controlling survival, chemotaxis, and actin dynamics, respectively.","evidence":"Glycolysis inhibition (2-DG) with CCR7 oligomerization and DC migration assays; pathway-specific pharmacological dissection of DC functions","pmids":["29941886","35281921"],"confidence":"High","gaps":["how glycolysis mechanistically promotes CCR7 oligomerization not resolved","whether metabolic requirement is specific to CCR7 or general for GPCRs not tested"]},{"year":2019,"claim":"Two major mechanistic advances defined endosomal and metabolic signaling: internalized CCR7/β-arrestin/Src complexes recruit Vav1–Rac1 at endomembranes to sustain lamellipodia formation; separately, CCR7 activates HIF-1α-driven glycolysis in DCs, with the lncRNA lnc-Dpf3 providing negative feedback by binding HIF-1α and suppressing Ldha transcription.","evidence":"Co-IP, proximity ligation, Rac1 photoactivation at endomembranes; DC-specific lnc-Dpf3 KO, RNA pull-down, m6A analysis, metabolic assays, in vivo DC migration","pmids":["31644919","30824325"],"confidence":"High","gaps":["whether endomembrane signaling occurs with CCL21 (which poorly internalizes CCR7) not addressed","generality of lnc-Dpf3 feedback beyond DCs unknown","structural basis of Src phosphorylation site on CCR7 not mapped"]},{"year":2021,"claim":"Systematic BRET assays comparing CCL19 and CCL21 in a uniform background found both ligands activate G proteins and recruit β-arrestin, with CCL19 showing higher potency but no clear qualitative bias, challenging earlier models of strict ligand-biased agonism.","evidence":"BRET-based G protein and β-arrestin recruitment assays in defined cellular system","pmids":["33921794"],"confidence":"Medium","gaps":["apparent conflict with in vivo differential internalization data not fully reconciled","assays in overexpression system may not recapitulate endogenous receptor density","lack of measurement of downstream effector bias (e.g., Akt vs. Erk)"]},{"year":2022,"claim":"CCR7's role extended to neutrophils: microbially stimulated neutrophils upregulate CCR7 and migrate to draining lymph nodes via lymphatics, where they are phagocytosed by DCs; separately, ACKR4 on lymphatic collector endothelium was identified as a scavenger of CCL19/CCL21 that shapes the chemotactic field enabling T cell transit.","evidence":"Neutrophil-specific CCR7-deficient chimeras, photoconvertible mouse tracking, S. aureus models; ACKR4-KO mice with intravital microscopy and flow-induced gene expression analysis","pmids":["35119939","35108538"],"confidence":"High","gaps":["signaling pathway in neutrophils vs. T cells/DCs not compared","whether ACKR4 shapes gradients for neutrophil migration as well is unknown"]},{"year":2023,"claim":"CCR7's role as both sensor and sink for CCL19 was demonstrated: ligand-induced internalization depletes local CCL19, creating self-generated gradients that drive collective DC migration and long-range guidance; in cancer, CCR7-PI3Kγ signaling was shown to confer ALK-inhibitor resistance and CNS dissemination in ALCL.","evidence":"Chemotaxis assays with mathematical modeling and gradient visualization; ALCL patient-derived xenografts, CCR7 genetic deletion, PI3Kγ/δ inhibitor duvelisib, constitutively active PI3Kγ model","pmids":["37656776","37379367"],"confidence":"High","gaps":["self-generated gradient mechanism not validated for CCL21","whether PI3Kγ dependence applies broadly to CCR7-driven cancers beyond ALCL is untested","structural basis of CCR7–PI3Kγ coupling not resolved"]},{"year":null,"claim":"Key unresolved questions include the structural basis of CCR7 homodimerization and ligand-selective internalization, the full phosphorylation code on CCR7's C-terminus that differentiates β-arrestin vs. G-protein outcomes, and whether therapeutic CCR7 antagonism can selectively block pathological (cancer/leukemia) migration without disrupting homeostatic immune cell trafficking.","evidence":"","pmids":[],"confidence":"Medium","gaps":["no high-resolution structure of CCR7 in complex with either ligand","phosphosite-specific mutagenesis linking C-tail phosphorylation to distinct signaling arms not performed","selective therapeutic targeting strategy not demonstrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,3,23]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[8,14,32]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,15,18,19]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[21]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[21]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,4,5,14,18,21,23,31,32]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,7,9,11,24,25,26]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[19,20]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[10,17,22,29,31]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,27,28]}],"complexes":[],"partners":["CCL19","CCL21","ARRB1","SRC","VAV1","RAC1","FOXO1","ACKR4"],"other_free_text":[]},"mechanistic_narrative":"CCR7 is a Gαi-coupled chemokine receptor that directs the migration and positioning of T cells, dendritic cells, and other leukocytes to and within secondary lymphoid organs by sensing gradients of its two ligands, CCL19 and CCL21. Signaling proceeds through largely independent downstream modules: PI3K/Akt promotes cell survival, MAPK governs chemotaxis, and RhoA/Rho kinase controls actin dynamics and cell polarization; additionally, CCR7 activates JAK2, ERK5–KLF-2 (upregulating S1P1 for lymph node egress), and HIF-1α (driving glycolytic reprogramming), while internalized CCR7–β-arrestin–Src complexes signal from endomembranes to recruit Vav1 and Rac1, sustaining lamellipodia formation during directed migration [PMID:9498785, PMID:12729902, PMID:12393730, PMID:22334704, PMID:30824325, PMID:31644919, PMID:32351499]. CCL19 induces rapid CCR7 internalization, desensitization, and self-generated chemokine gradient depletion that enables collective long-range guidance, whereas CCL21 does not trigger internalization, permitting persistent surface signaling; receptor function is further tuned by N-glycosylation/sialylation, homodimerization, glycolysis-dependent oligomerization, transcriptional regulation by FOXO1, EBNA2, and Notch1, and epigenetic silencing by H3K27me3 [PMID:11745346, PMID:37656776, PMID:26819318, PMID:28819198, PMID:29941886, PMID:25786691, PMID:7488016, PMID:19536265, PMID:25297875]. Beyond homeostatic lymphocyte homing, CCR7 is co-opted in disease: Notch1-driven CCR7 expression mediates T-ALL infiltration of the CNS, CCR7-dependent PI3Kγ signaling confers resistance to ALK inhibitors in ALCL, and CCR7 on breast cancer cells promotes lymphangiogenesis via AKT-driven VEGF-C secretion [PMID:19536265, PMID:37379367, PMID:25744065]."},"prefetch_data":{"uniprot":{"accession":"P32248","full_name":"C-C chemokine receptor type 7","aliases":["BLR2","CDw197","Epstein-Barr virus-induced G-protein coupled receptor 1","EBI1","EBV-induced G-protein coupled receptor 1","MIP-3 beta receptor"],"length_aa":378,"mass_kda":42.9,"function":"Receptor for the MIP-3-beta chemokine. Probable mediator of EBV effects on B-lymphocytes or of normal lymphocyte functions","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P32248/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CCR7","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CCR7","total_profiled":1310},"omim":[{"mim_id":"617237","title":"IMMUNODEFICIENCY 49, SEVERE COMBINED; IMD49","url":"https://www.omim.org/entry/617237"},{"mim_id":"611195","title":"JANUS KINASE AND MICROTUBULE-INTERACTING PROTEIN 1; JAKMIP1","url":"https://www.omim.org/entry/611195"},{"mim_id":"610369","title":"HEAT-SHOCK 70-KD PROTEIN 14; HSPA14","url":"https://www.omim.org/entry/610369"},{"mim_id":"609662","title":"NLR FAMILY, PYRIN DOMAIN-CONTAINING 10; NLRP10","url":"https://www.omim.org/entry/609662"},{"mim_id":"608957","title":"IMMUNODEFICIENCY 116; IMD116","url":"https://www.omim.org/entry/608957"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":19.7},{"tissue":"lymphoid tissue","ntpm":78.7}],"url":"https://www.proteinatlas.org/search/CCR7"},"hgnc":{"alias_symbol":["BLR2","CDw197","CD197"],"prev_symbol":["CMKBR7","EBI1"]},"alphafold":{"accession":"P32248","domains":[{"cath_id":"1.20.1070.10","chopping":"50-338","consensus_level":"medium","plddt":86.1547,"start":50,"end":338}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P32248","model_url":"https://alphafold.ebi.ac.uk/files/AF-P32248-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P32248-F1-predicted_aligned_error_v6.png","plddt_mean":78.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CCR7","jax_strain_url":"https://www.jax.org/strain/search?query=CCR7"},"sequence":{"accession":"P32248","fasta_url":"https://rest.uniprot.org/uniprotkb/P32248.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P32248/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P32248"}},"corpus_meta":[{"pmid":"18379575","id":"PMC_18379575","title":"CCR7 and its ligands: balancing immunity and tolerance.","date":"2008","source":"Nature reviews. Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18379575","citation_count":1140,"is_preprint":false},{"pmid":"15308107","id":"PMC_15308107","title":"CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions.","date":"2004","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15308107","citation_count":800,"is_preprint":false},{"pmid":"9153236","id":"PMC_9153236","title":"Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9153236","citation_count":323,"is_preprint":false},{"pmid":"24378538","id":"PMC_24378538","title":"CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets.","date":"2013","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24378538","citation_count":318,"is_preprint":false},{"pmid":"30824325","id":"PMC_30824325","title":"CCR7 Chemokine Receptor-Inducible lnc-Dpf3 Restrains Dendritic Cell Migration by Inhibiting HIF-1α-Mediated Glycolysis.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/30824325","citation_count":293,"is_preprint":false},{"pmid":"12019175","id":"PMC_12019175","title":"Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12019175","citation_count":266,"is_preprint":false},{"pmid":"16203865","id":"PMC_16203865","title":"IL-18-induced CD83+CCR7+ NK helper cells.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16203865","citation_count":235,"is_preprint":false},{"pmid":"19536265","id":"PMC_19536265","title":"CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia.","date":"2009","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19536265","citation_count":222,"is_preprint":false},{"pmid":"11929789","id":"PMC_11929789","title":"The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11929789","citation_count":175,"is_preprint":false},{"pmid":"29941886","id":"PMC_29941886","title":"Glycolytic metabolism is essential for CCR7 oligomerization and dendritic cell migration.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29941886","citation_count":172,"is_preprint":false},{"pmid":"16272303","id":"PMC_16272303","title":"Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16272303","citation_count":159,"is_preprint":false},{"pmid":"15302903","id":"PMC_15302903","title":"Thymic T cell development and progenitor localization depend on CCR7.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15302903","citation_count":157,"is_preprint":false},{"pmid":"15073111","id":"PMC_15073111","title":"CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.","date":"2004","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/15073111","citation_count":150,"is_preprint":false},{"pmid":"12732661","id":"PMC_12732661","title":"Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs.","date":"2003","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12732661","citation_count":136,"is_preprint":false},{"pmid":"25744065","id":"PMC_25744065","title":"The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.","date":"2015","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25744065","citation_count":115,"is_preprint":false},{"pmid":"11745346","id":"PMC_11745346","title":"The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC.","date":"2001","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11745346","citation_count":105,"is_preprint":false},{"pmid":"15767451","id":"PMC_15767451","title":"Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7.","date":"2005","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/15767451","citation_count":103,"is_preprint":false},{"pmid":"9498785","id":"PMC_9498785","title":"CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9498785","citation_count":102,"is_preprint":false},{"pmid":"32017846","id":"PMC_32017846","title":"CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32017846","citation_count":86,"is_preprint":false},{"pmid":"9701028","id":"PMC_9701028","title":"EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC.","date":"1998","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9701028","citation_count":85,"is_preprint":false},{"pmid":"32340161","id":"PMC_32340161","title":"The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32340161","citation_count":79,"is_preprint":false},{"pmid":"7488016","id":"PMC_7488016","title":"Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7488016","citation_count":77,"is_preprint":false},{"pmid":"35281921","id":"PMC_35281921","title":"New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35281921","citation_count":73,"is_preprint":false},{"pmid":"15557160","id":"PMC_15557160","title":"Impact of CCR7 on priming and distribution of antiviral effector and memory CTL.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15557160","citation_count":71,"is_preprint":false},{"pmid":"17515886","id":"PMC_17515886","title":"The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking.","date":"2007","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/17515886","citation_count":69,"is_preprint":false},{"pmid":"26819318","id":"PMC_26819318","title":"Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses.","date":"2016","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/26819318","citation_count":67,"is_preprint":false},{"pmid":"12393730","id":"PMC_12393730","title":"CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12393730","citation_count":64,"is_preprint":false},{"pmid":"24990081","id":"PMC_24990081","title":"Differential requirement for CCR4 and CCR7 during the development of innate and adaptive αβT cells in the adult thymus.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24990081","citation_count":62,"is_preprint":false},{"pmid":"25019368","id":"PMC_25019368","title":"CCR7: roles in cancer cell dissemination, migration and metastasis formation.","date":"2014","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25019368","citation_count":61,"is_preprint":false},{"pmid":"17462953","id":"PMC_17462953","title":"A key role for CCR7 in establishing central and peripheral tolerance.","date":"2007","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17462953","citation_count":59,"is_preprint":false},{"pmid":"24725321","id":"PMC_24725321","title":"The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation.","date":"2013","source":"The ocular surface","url":"https://pubmed.ncbi.nlm.nih.gov/24725321","citation_count":57,"is_preprint":false},{"pmid":"10861057","id":"PMC_10861057","title":"Macrophage-derived chemokine and EBI1-ligand chemokine attract human thymocytes in different stage of development and are produced by distinct subsets of medullary epithelial cells: possible implications for negative selection.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10861057","citation_count":55,"is_preprint":false},{"pmid":"9725259","id":"PMC_9725259","title":"Macrophage-inflammatory protein-3 beta/EBI1-ligand chemokine/CK beta-11, a CC chemokine, is a chemoattractant with a specificity for macrophage progenitors among myeloid progenitor cells.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9725259","citation_count":55,"is_preprint":false},{"pmid":"12729902","id":"PMC_12729902","title":"Rho kinase is required for CCR7-mediated polarization and chemotaxis of T lymphocytes.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12729902","citation_count":53,"is_preprint":false},{"pmid":"27248053","id":"PMC_27248053","title":"CXCR4 and CCR7: Two eligible targets in targeted cancer therapy.","date":"2016","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/27248053","citation_count":52,"is_preprint":false},{"pmid":"38267413","id":"PMC_38267413","title":"Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38267413","citation_count":52,"is_preprint":false},{"pmid":"28819198","id":"PMC_28819198","title":"Regulation of CCR7-dependent cell migration through CCR7 homodimer formation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28819198","citation_count":51,"is_preprint":false},{"pmid":"22700449","id":"PMC_22700449","title":"Multifaceted activities of CCR7 regulate T-cell homeostasis in health and disease.","date":"2012","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22700449","citation_count":51,"is_preprint":false},{"pmid":"29973648","id":"PMC_29973648","title":"The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy.","date":"2018","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29973648","citation_count":51,"is_preprint":false},{"pmid":"12851649","id":"PMC_12851649","title":"Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking.","date":"2003","source":"Microcirculation (New York, N.Y. : 1994)","url":"https://pubmed.ncbi.nlm.nih.gov/12851649","citation_count":51,"is_preprint":false},{"pmid":"32655968","id":"PMC_32655968","title":"The Roles of CCR7 for the Homing of Memory CD8+ T Cells into Their Survival Niches.","date":"2020","source":"Immune network","url":"https://pubmed.ncbi.nlm.nih.gov/32655968","citation_count":51,"is_preprint":false},{"pmid":"25786691","id":"PMC_25786691","title":"FOXO1 regulates dendritic cell activity through ICAM-1 and CCR7.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25786691","citation_count":50,"is_preprint":false},{"pmid":"12406901","id":"PMC_12406901","title":"Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12406901","citation_count":50,"is_preprint":false},{"pmid":"18544997","id":"PMC_18544997","title":"Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer.","date":"2008","source":"Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18544997","citation_count":49,"is_preprint":false},{"pmid":"19513547","id":"PMC_19513547","title":"CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer.","date":"2009","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19513547","citation_count":48,"is_preprint":false},{"pmid":"32351499","id":"PMC_32351499","title":"The Chemokine Receptor CCR7 Uses Distinct Signaling Modules With Biased Functionality to Regulate Dendritic Cells.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32351499","citation_count":46,"is_preprint":false},{"pmid":"18838387","id":"PMC_18838387","title":"Functional expression of the chemokine receptor CCR7 on fibroblast-like synoviocytes.","date":"2008","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18838387","citation_count":44,"is_preprint":false},{"pmid":"27774094","id":"PMC_27774094","title":"Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor.","date":"2016","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27774094","citation_count":44,"is_preprint":false},{"pmid":"20194718","id":"PMC_20194718","title":"The actin-bundling protein L-plastin dissociates CCR7 proximal signaling from CCR7-induced motility.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20194718","citation_count":43,"is_preprint":false},{"pmid":"25139737","id":"PMC_25139737","title":"CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/25139737","citation_count":43,"is_preprint":false},{"pmid":"30940644","id":"PMC_30940644","title":"Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway.","date":"2019","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/30940644","citation_count":43,"is_preprint":false},{"pmid":"23649655","id":"PMC_23649655","title":"CCL19/CCR7 upregulates heparanase via specificity protein-1 (Sp1) to promote invasion of cell in lung cancer.","date":"2013","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23649655","citation_count":40,"is_preprint":false},{"pmid":"17982037","id":"PMC_17982037","title":"CCR7 signaling inhibits T cell proliferation.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17982037","citation_count":39,"is_preprint":false},{"pmid":"37656776","id":"PMC_37656776","title":"CCR7 acts as both a sensor and a sink for CCL19 to coordinate collective leukocyte migration.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37656776","citation_count":39,"is_preprint":false},{"pmid":"19017956","id":"PMC_19017956","title":"Dynamic modulation of CCR7 expression and function on naive T lymphocytes in vivo.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19017956","citation_count":38,"is_preprint":false},{"pmid":"30692988","id":"PMC_30692988","title":"Maturing Human CD127+ CCR7+ PDL1+ Dendritic Cells Express AIRE in the Absence of Tissue Restricted Antigens.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30692988","citation_count":38,"is_preprint":false},{"pmid":"21195108","id":"PMC_21195108","title":"Chicken CCR6 and CCR7 are markers for immature and mature dendritic cells respectively.","date":"2010","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21195108","citation_count":36,"is_preprint":false},{"pmid":"27207557","id":"PMC_27207557","title":"CCR7 Maintains Nonresolving Lymph Node and Adipose Inflammation in Obesity.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27207557","citation_count":34,"is_preprint":false},{"pmid":"25772241","id":"PMC_25772241","title":"The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25772241","citation_count":34,"is_preprint":false},{"pmid":"32499193","id":"PMC_32499193","title":"The pathogenic importance of CCL21 and CCR7 in rheumatoid arthritis.","date":"2020","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/32499193","citation_count":33,"is_preprint":false},{"pmid":"26115234","id":"PMC_26115234","title":"Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites.","date":"2015","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26115234","citation_count":33,"is_preprint":false},{"pmid":"23180724","id":"PMC_23180724","title":"Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice.","date":"2012","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/23180724","citation_count":33,"is_preprint":false},{"pmid":"17975098","id":"PMC_17975098","title":"Enhanced responsiveness and sensitivity to blue light by blr-2 overexpression in Trichoderma atroviride.","date":"2007","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17975098","citation_count":32,"is_preprint":false},{"pmid":"16786131","id":"PMC_16786131","title":"Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular cancer.","date":"2006","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/16786131","citation_count":32,"is_preprint":false},{"pmid":"16223574","id":"PMC_16223574","title":"Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses.","date":"2005","source":"Auris, nasus, larynx","url":"https://pubmed.ncbi.nlm.nih.gov/16223574","citation_count":32,"is_preprint":false},{"pmid":"26504105","id":"PMC_26504105","title":"Differential ligand-signaling network of CCL19/CCL21-CCR7 system.","date":"2015","source":"Database : the journal of biological databases and curation","url":"https://pubmed.ncbi.nlm.nih.gov/26504105","citation_count":32,"is_preprint":false},{"pmid":"16394278","id":"PMC_16394278","title":"Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia.","date":"2006","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16394278","citation_count":32,"is_preprint":false},{"pmid":"27814720","id":"PMC_27814720","title":"miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7.","date":"2016","source":"BMC urology","url":"https://pubmed.ncbi.nlm.nih.gov/27814720","citation_count":32,"is_preprint":false},{"pmid":"25297875","id":"PMC_25297875","title":"Epigenetic control of Ccr7 expression in distinct lineages of lung dendritic cells.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25297875","citation_count":31,"is_preprint":false},{"pmid":"31644919","id":"PMC_31644919","title":"Chemokine Receptor CCR7 Triggers an Endomembrane Signaling Complex for Spatial Rac Activation.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31644919","citation_count":29,"is_preprint":false},{"pmid":"19759904","id":"PMC_19759904","title":"Jak3 is involved in dendritic cell maturation and CCR7-dependent migration.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19759904","citation_count":29,"is_preprint":false},{"pmid":"17096832","id":"PMC_17096832","title":"Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors.","date":"2006","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17096832","citation_count":29,"is_preprint":false},{"pmid":"20638137","id":"PMC_20638137","title":"CCR7 is expressed in astrocytes and upregulated after an inflammatory injury.","date":"2010","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/20638137","citation_count":29,"is_preprint":false},{"pmid":"35119939","id":"PMC_35119939","title":"CCR7-guided neutrophil redirection to skin-draining lymph nodes regulates cutaneous inflammation and infection.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35119939","citation_count":28,"is_preprint":false},{"pmid":"35108538","id":"PMC_35108538","title":"Mechanosensitive ACKR4 scavenges CCR7 chemokines to facilitate T cell de-adhesion and passive transport by flow in inflamed afferent lymphatics.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35108538","citation_count":28,"is_preprint":false},{"pmid":"22990666","id":"PMC_22990666","title":"CCR7+ central and CCR7- effector memory CD4+ T cells in human cutaneous leishmaniasis.","date":"2012","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22990666","citation_count":28,"is_preprint":false},{"pmid":"20028772","id":"PMC_20028772","title":"CCR7 regulates lymphocyte egress and recirculation through body cavities.","date":"2009","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/20028772","citation_count":28,"is_preprint":false},{"pmid":"16189151","id":"PMC_16189151","title":"Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease.","date":"2005","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16189151","citation_count":27,"is_preprint":false},{"pmid":"29784760","id":"PMC_29784760","title":"Formation of the Intrathymic Dendritic Cell Pool Requires CCL21-Mediated Recruitment of CCR7+ Progenitors to the Thymus.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29784760","citation_count":27,"is_preprint":false},{"pmid":"31068931","id":"PMC_31068931","title":"Elevated CCL19/CCR7 Expression During the Disease Process of Primary Sjögren's Syndrome.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31068931","citation_count":27,"is_preprint":false},{"pmid":"33110606","id":"PMC_33110606","title":"CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.","date":"2020","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/33110606","citation_count":27,"is_preprint":false},{"pmid":"28694053","id":"PMC_28694053","title":"Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.","date":"2017","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28694053","citation_count":26,"is_preprint":false},{"pmid":"22334704","id":"PMC_22334704","title":"CCR7/CCL19 controls expression of EDG-1 in T cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22334704","citation_count":26,"is_preprint":false},{"pmid":"25257053","id":"PMC_25257053","title":"Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/25257053","citation_count":26,"is_preprint":false},{"pmid":"30518137","id":"PMC_30518137","title":"Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30518137","citation_count":25,"is_preprint":false},{"pmid":"27031839","id":"PMC_27031839","title":"Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis.","date":"2016","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/27031839","citation_count":25,"is_preprint":false},{"pmid":"19923454","id":"PMC_19923454","title":"CCR7 modulates pulmonary and lymph node inflammatory responses in cigarette smoke-exposed mice.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19923454","citation_count":25,"is_preprint":false},{"pmid":"35133060","id":"PMC_35133060","title":"CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels.","date":"2022","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/35133060","citation_count":24,"is_preprint":false},{"pmid":"24528991","id":"PMC_24528991","title":"Correlation between CCR7 expression and lymph node metastatic potential of human tongue carcinoma.","date":"2014","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24528991","citation_count":24,"is_preprint":false},{"pmid":"21969271","id":"PMC_21969271","title":"Deficient CCR7 signaling promotes TH2 polarization and B-cell activation in vivo.","date":"2011","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21969271","citation_count":24,"is_preprint":false},{"pmid":"28137279","id":"PMC_28137279","title":"Interplay between CCR7 and Notch1 axes promotes stemness in MMTV-PyMT mammary cancer cells.","date":"2017","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28137279","citation_count":23,"is_preprint":false},{"pmid":"31493920","id":"PMC_31493920","title":"RAGE and CCR7 mediate the transmigration of Zika-infected monocytes through the blood-brain barrier.","date":"2019","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/31493920","citation_count":23,"is_preprint":false},{"pmid":"24500801","id":"PMC_24500801","title":"CCR7-mediated migration in the thymus controls γδ T-cell development.","date":"2014","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24500801","citation_count":22,"is_preprint":false},{"pmid":"22619482","id":"PMC_22619482","title":"oxLDL downregulates the dendritic cell homing factors CCR7 and CCL21.","date":"2012","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22619482","citation_count":22,"is_preprint":false},{"pmid":"28767178","id":"PMC_28767178","title":"Chemokine receptor-7 (CCR7) deficiency leads to delayed development of joint damage and functional deficits in a murine model of osteoarthritis.","date":"2017","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/28767178","citation_count":22,"is_preprint":false},{"pmid":"33921794","id":"PMC_33921794","title":"Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33921794","citation_count":21,"is_preprint":false},{"pmid":"28239467","id":"PMC_28239467","title":"CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo.","date":"2017","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28239467","citation_count":21,"is_preprint":false},{"pmid":"30785638","id":"PMC_30785638","title":"CCL21-expression and accumulation of CCR7+ NK cells in livers of patients with primary sclerosing cholangitis.","date":"2019","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30785638","citation_count":20,"is_preprint":false},{"pmid":"17966215","id":"PMC_17966215","title":"Expression of the CXCR4 and CCR7 chemokine receptors in human endometrial cancer.","date":"2007","source":"European journal of gynaecological oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17966215","citation_count":20,"is_preprint":false},{"pmid":"37379367","id":"PMC_37379367","title":"Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.","date":"2023","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37379367","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46692,"output_tokens":8116,"usd":0.130908},"stage2":{"model":"claude-opus-4-6","input_tokens":11936,"output_tokens":5465,"usd":0.294457},"total_usd":0.425365,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"CCL19 (ELC) was identified as a specific, high-affinity functional ligand for CCR7 (EBI1): recombinant ELC-alkaline phosphatase fusion protein bound specifically to CCR7-transfected cells, and ELC induced calcium mobilization and chemotaxis exclusively through CCR7 among five CC chemokine receptors and five orphan receptors tested.\",\n      \"method\": \"Receptor-binding assay with alkaline phosphatase-fused ligand, calcium mobilization assay, chemotaxis assay in stably transfected cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal in vitro assays (binding, calcium flux, chemotaxis) with specificity controls across multiple receptors\",\n      \"pmids\": [\"9153236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CCR7-mediated chemotaxis in lymphocytes is coupled to a Gαi protein, as demonstrated by complete blockade with pertussis toxin; CCL19 (CK beta-11/MIP-3β/ELC) induced actin polymerization and calcium mobilization in T and B cells via CCR7.\",\n      \"method\": \"Chemotaxis assay with pertussis toxin inhibition, actin polymerization assay, calcium mobilization assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — pertussis toxin inhibition directly demonstrates Gαi coupling; multiple orthogonal functional assays\",\n      \"pmids\": [\"9498785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"CCR7 (BLR2/EBI1) gene transcription is specifically induced by Epstein-Barr virus nuclear antigen 2 (EBNA2) in B cells, identifying EBNA2 as a transcriptional activator of CCR7.\",\n      \"method\": \"Northern blot, estrogen-inducible EBNA2 activation system in EBV-negative BL41 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct transcriptional induction shown by Northern blot with inducible EBNA2 system, single lab\",\n      \"pmids\": [\"7488016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CCL19 (ELC) and CCL21 (SLC) differ fundamentally in their ability to induce CCR7 internalization: CCL19 rapidly induces CCR7 internalization and receptor desensitization in a time- and concentration-dependent manner, whereas CCL21 does not trigger internalization, allowing persistent CCR7 surface expression and continued responsiveness.\",\n      \"method\": \"Flow cytometry-based receptor redistribution assay, functional desensitization assay in CCR7-bearing T lymphocytes\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct receptor internalization measured by flow cytometry with functional desensitization readout; clear differential between two ligands\",\n      \"pmids\": [\"11745346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CCR7 mediates lymphocyte homing to peripheral lymph nodes through a JAK tyrosine kinase-dependent pathway: the JAK inhibitor Tyrphostin AG490 blocked CCR7-mediated chemotaxis and CCL21-induced α4/β2 integrin upregulation, and CCL21 stimulation induced rapid Jak2 phosphorylation in primary mouse lymphocytes; in vivo, AG490-treated lymphocytes showed significantly reduced adhesion in high endothelial venules.\",\n      \"method\": \"Pharmacological inhibition (Tyrphostin AG490), static and flow adhesion assays, intravital microscopy, Jak2 phosphorylation by western blot\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (in vitro chemotaxis, adhesion assays, in vivo intravital microscopy, biochemical phosphorylation); single lab but comprehensive\",\n      \"pmids\": [\"12393730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CCR7-mediated T lymphocyte polarization and chemotaxis require Rho kinase: inhibition of Rho kinase isoforms with Y-27632 strongly blocked CCL19- and CCL21-induced polarized morphology and chemotaxis, whereas blockade of ERK2 had no effect on these processes.\",\n      \"method\": \"Pharmacological inhibition (Y-27632 for Rho kinase; ERK inhibitor), T lymphocyte chemotaxis and polarization assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibition with clear functional readouts; single lab\",\n      \"pmids\": [\"12729902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CCR7 is essential for dendritic cell entry into dermal lymphatic vessels and for DC migration to skin-draining lymph nodes under both inflammatory and steady-state conditions; CCR7-deficient mice lacked a population of semimature tolerogenic DCs in skin-draining lymph nodes.\",\n      \"method\": \"CCR7 knockout mouse model, flow cytometry, immunohistology, DC trafficking assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined cellular phenotype replicated across inflammatory and steady-state conditions; highly cited foundational paper\",\n      \"pmids\": [\"15308107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CCR7 signaling regulates the migration of early T cell progenitors from the cortico-medullary junction toward the outer thymic cortex; CCR7-deficient mice show disturbed thymic architecture, impaired T cell development, and accumulation of CD25+CD44+ cells at the cortico-medullary junction.\",\n      \"method\": \"CCR7 knockout mouse model, immunohistology, mixed bone marrow chimeras, flow cytometry\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with mechanistic localization data and mixed chimera confirmation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"15302903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CCR7 signaling inhibits T cell proliferation and IL-2 secretion: sustained engagement of CCR7 by high concentrations of soluble or immobilized CCL19/CCL21 induces cell cycle arrest associated with delayed degradation of the CDK inhibitor p27Kip1 and downregulation of CDK1; CCR7 knockout T cells show increased proliferative responses, confirming receptor specificity.\",\n      \"method\": \"T cell proliferation assays with soluble/immobilized ligand, CCR7 KO comparison, western blot for p27Kip1 and CDK1\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO rescue controls, biochemical mechanism (p27Kip1/CDK1), multiple conditions; single lab\",\n      \"pmids\": [\"17982037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CCR7 in vivo surface expression and occupancy are dynamically modulated by its ligands: in secondary lymphoid organs (but not blood), most T cell CCR7 is occupied by CCL19, leading to continuous signaling and reduced ligand sensitivity; both ligands trigger CCR7 internalization in vivo as shown in Ccl19-deficient and plt/plt mice.\",\n      \"method\": \"In vivo CCR7 occupancy analysis, Ccl19-/- and plt/plt mice, in vitro internalization assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models (KO mice) with in vivo and in vitro orthogonal assays\",\n      \"pmids\": [\"19017956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCR7 expression in T-ALL is transcriptionally controlled by the Notch1 oncogene; CCR7 (and its ligand CCL19) is the essential signal required for leukaemic T-cell infiltration of the CNS—silencing either CCR7 or CCL19 specifically inhibits CNS infiltration in a mouse T-ALL model.\",\n      \"method\": \"Gene expression profiling, T-ALL animal modeling, CCR7/CCL19 silencing (genetic), xenograft with human T-ALL cells\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (Notch1 → CCR7) with in vivo silencing; multiple animal models including human xenograft\",\n      \"pmids\": [\"19536265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CCR7 controls lymphocyte egress from body cavities: CCR7 deficiency causes massive accumulation of CD4+, CD8+ T cells and B-2 B cells in the peritoneal and pleural cavities due to impaired CCR7-dependent lymphocyte exit, not altered maturation status.\",\n      \"method\": \"CCR7 knockout mouse model, flow cytometry of peritoneal/pleural lavage cells, lymphocyte recirculation assays\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with specific cellular phenotype; single lab\",\n      \"pmids\": [\"20028772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The actin-bundling protein L-plastin (LPL) is required for CCR7-mediated T cell motility: LPL-deficient T cells fail to polarize CCR7 to the leading edge upon CCR7 ligation, resulting in defective chemotaxis and reduced thymic egress in vivo; however, CCR7 signaling to F-actin polymerization and CCR7-mediated costimulation remain intact in LPL-/- cells.\",\n      \"method\": \"LPL knockout mice, two-photon microscopy of lymph nodes, intravital migration assays, receptor localization imaging, thymic egress assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with in vivo (two-photon) and in vitro dissection of signaling vs. motility; multiple orthogonal methods\",\n      \"pmids\": [\"20194718\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CCR7/CCL19 signaling upregulates EDG-1 (S1P1) expression in T cells via an ERK5–KLF-2 signaling axis: CCL19 stimulation induces ERK5 phosphorylation and increased expression of the transcription factor KLF-2 and subsequently EDG-1, which mediates T cell egress from lymph nodes; ERK5 deletion in T cells (Lck-Cre) abolishes this CCL19-induced EDG-1 upregulation.\",\n      \"method\": \"T cell stimulation assays, ERK5-flox/Lck-Cre conditional KO mice, migration assays to S1P ligands, western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic conditional KO with pathway mechanistic follow-up (ERK5→KLF-2→EDG-1); multiple orthogonal methods\",\n      \"pmids\": [\"22334704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CCR7 uses distinct, largely independent signaling modules in dendritic cells with biased functionality: PI3K/Akt controls DC survival, the MAPK pathway controls chemotaxis, and the RhoA pathway controls actin dynamics, migratory speed, cytoarchitecture, and endocytosis.\",\n      \"method\": \"Pharmacological inhibition of individual signaling pathways, DC functional assays (survival, chemotaxis, speed, endocytosis), biochemical pathway analysis\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological inhibitors dissecting signaling modules; single lab\",\n      \"pmids\": [\"32351499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CCR7 is N-glycosylated at two specific residues in the N-terminus and third extracellular loop; glycosylation (particularly sialylation) dampens CCR7 signaling and receptor endocytosis, thereby restraining chemotactic responses. Dendritic cells boost T cell migration by secreting deglycosylating enzymes that remove sialylation from CCR7 on T cells, and also proteolytically convert immobilized CCL21 to a soluble form with distinct signaling properties.\",\n      \"method\": \"Mutagenesis of glycosylation sites, enzymatic deglycosylation, flow cytometry, migration assays, receptor endocytosis assays; metabolic glycan labeling\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis of specific sites combined with enzymatic deglycosylation and multiple functional readouts; mechanistically comprehensive\",\n      \"pmids\": [\"26819318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CCL19 NMR solution structure reveals a canonical chemokine fold; chemical shift mapping shows that the N-termini of PSGL-1 and CCR7 have overlapping, competitive binding sites for CCL19, providing a structural basis for PSGL-1 enhancement of T cell recruitment.\",\n      \"method\": \"NMR solution structure determination, chemical shift perturbation mapping, competitive binding assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with functional binding site mapping; competitive assay validation\",\n      \"pmids\": [\"26115234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CCR7 expression on breast cancer cells promotes tumor lymphangiogenesis via VEGF-C secretion through the AKT signaling pathway: CCR7-mediated AKT activation drives VEGF-C secretion, which promotes lymphatic endothelial cell proliferation, migration, and tube formation.\",\n      \"method\": \"CCR7/CCL21 gene-manipulated orthotopic xenograft mouse model, in vitro lymphangiogenesis assays (proliferation, migration, tube formation), AKT inhibition, ELISA\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro with pathway inhibition; single lab\",\n      \"pmids\": [\"25744065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CCR7 homodimerization directly regulates CCR7-dependent cell migration and signaling: induction of stable CCR7 homodimers enhanced cell migration and CCL19 binding, while a novel CCR7-derived synthetic peptide that disrupted homodimerization attenuated CCR7-dependent migration, ligand-induced internalization, actin rearrangement, and Akt/Erk signaling.\",\n      \"method\": \"CCR7 homodimer induction/disruption (synthetic peptide), CXCR4/CCR7 heterodimerization experiments, migration assays, ligand-binding assays, internalization assays, signaling (Akt/Erk) western blot\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional manipulation (induction and disruption) of dimerization with multiple orthogonal functional and biochemical readouts\",\n      \"pmids\": [\"28819198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Glycolytic metabolism is required for CCR7 oligomerization and DC migration to draining lymph nodes: early glycolysis induction (via AKT, TBK, mTOR activation) supports elongated DC morphology, CCR7 oligomerization on the cell surface, and DC motility; inhibiting glycolysis impairs these functions regardless of mitochondrial bioenergetics.\",\n      \"method\": \"Glycolysis inhibition (2-DG), AKT/TBK/mTOR pathway analysis, CCR7 oligomerization assays, DC motility assays, in vivo DC migration to lymph nodes\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — pharmacological and genetic inhibition with mechanistic link to CCR7 oligomerization; multiple orthogonal methods in vitro and in vivo\",\n      \"pmids\": [\"29941886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CCR7 stimulation activates the HIF-1α transcription factor pathway in DCs, inducing metabolic reprogramming toward glycolysis to fuel DC migration; CCR7 stimulation also upregulates the lncRNA lnc-Dpf3 by removing m6A methylation to prevent RNA degradation. lnc-Dpf3 then directly binds HIF-1α and suppresses HIF-1α-dependent transcription of the glycolytic gene Ldha, creating a negative feedback loop that restrains CCR7-mediated DC migration.\",\n      \"method\": \"DC-specific lnc-Dpf3 knockout, RNA pull-down/RIP for lnc-Dpf3:HIF-1α interaction, m6A modification analysis, metabolic (glycolysis) assays, in vivo DC migration assays, inflammatory disease models\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — cell-specific KO, direct molecular interaction (lnc-Dpf3:HIF-1α), mechanistic pathway with m6A epigenetic regulation; multiple orthogonal methods\",\n      \"pmids\": [\"30824325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CCR7 signals from endomembrane compartments to sustain directed DC migration: upon CCL19 binding, β-arrestin and Src kinase are co-trafficked with internalized CCR7 to endosomes; Src tyrosine-phosphorylates CCR7 at endomembranes, recruiting Vav1 (a RhoGEF) and Rac1 to form a multi-protein signaling complex; photoactivation of Rac1 at endomembranes drives lamellipodia formation at the leading edge.\",\n      \"method\": \"Co-immunoprecipitation, proximity ligation assay, vesicular trafficking inhibition, Src kinase mutagenesis, Rac1 photoactivation, live-cell imaging\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including mutagenesis, protein interaction assays, and spatially resolved Rac1 photoactivation; mechanistically comprehensive\",\n      \"pmids\": [\"31644919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CCL21/CCR7 axis promotes EMT and cancer stemness in OSCC via JAK2/STAT3 pathway: CCL21 stimulation markedly increased phospho-JAK2 and phospho-STAT3; JAK2/STAT3 inhibition suppressed CCL21-induced EMT and stemness markers; CCR7 knockdown blocked these effects.\",\n      \"method\": \"CCR7 knockdown/overexpression, JAK2/STAT3 inhibitor treatment, western blot for EMT and stemness markers, migration/invasion/tumorsphere assays\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KD and pharmacological inhibition with multiple functional readouts; single lab\",\n      \"pmids\": [\"32017846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"At CCR7, CCL19 and CCL21 both stimulate G protein signaling and β-arrestin recruitment, with CCL19 consistently displaying higher potency; this systematic comparison in the same cellular background reveals CCR7's intrinsic coupling capabilities without evidence of ligand-biased agonism between CCL19 and CCL21.\",\n      \"method\": \"Systematic BRET-based G protein activation and β-arrestin recruitment assays in a uniform cellular background\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — systematic in vitro signaling assays in defined cellular system; single study\",\n      \"pmids\": [\"33921794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Neutrophils upregulate CCR7 in response to microbial stimuli and migrate from inflamed skin to draining lymph nodes via lymphatic vessels in a CCR7-dependent manner; in the lymph nodes, these neutrophils are phagocytosed by resident cDC1 and cDC2, and CCR7-deficient neutrophils show increased antistaphylococcal immunity and aggravated skin inflammation.\",\n      \"method\": \"Selective CCR7 deficiency on neutrophils (bone marrow chimeras), photoconvertible mouse tracking, mouse models of TLR-induced skin inflammation and S. aureus infection, flow cytometry\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with in vivo trafficking and functional consequences; multiple disease models\",\n      \"pmids\": [\"35119939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ACKR4 (atypical chemokine receptor 4) expressed on lymphatic collector endothelium acts as a flow-induced scavenger of CCL19 and CCL21, enabling T cell detachment from the vessel wall and transition to free-flow transport toward draining lymph nodes; loss of ACKR4 causes T cell accumulation in dermal collecting vessel segments.\",\n      \"method\": \"ACKR4-deficient mice, flow-induced gene expression analysis, T cell trafficking assays in TPA-induced inflammation, intravital microscopy\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with precise in vivo trafficking readout and mechanistic link to CCR7 ligand scavenging\",\n      \"pmids\": [\"35108538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CCR7 acts as both a sensor and a sink for CCL19: upon CCL19 binding, DCs internalize CCR7 together with CCL19 as part of canonical GPCR desensitization, which depletes the local chemokine and dynamically reshapes the chemotactic gradient. This self-generated gradient mechanism drives collective DC migration, enables long-range guidance, and allows DCs to guide comigrating cells.\",\n      \"method\": \"Experimental chemotaxis assays combined with mathematical modeling, CCR7 internalization tracking, chemokine gradient visualization, collective migration assays\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — integration of experimental data with quantitative theory; multiple orthogonal experimental validations of gradient-shaping mechanism\",\n      \"pmids\": [\"37656776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Epigenetic silencing of the Ccr7 locus by H3K27me3 (trimethylation of histone 3 lysine 27) controls differential CCR7 expression between conventional DCs and monocyte-derived DCs in the lung, and this epigenetic modification is acquired gradually during monocyte-to-moDC differentiation rather than at early lineage commitment.\",\n      \"method\": \"ChIP-seq/ChIP-PCR for H3K27me3, comparison of bone marrow-derived and lung DC subsets, monocyte differentiation time-course\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP analysis at defined locus with developmental time-course; single lab\",\n      \"pmids\": [\"25297875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FOXO1 directly binds the CCR7 promoter and stimulates CCR7 transcriptional activity in dendritic cells; FOXO1 nuclear localization is induced by bacteria through the MAPK pathway, and FOXO1-dependent CCR7 expression is required for DC chemotaxis and lymph node homing in vivo.\",\n      \"method\": \"ChIP assay for FOXO1 binding at CCR7 promoter, luciferase reporter assay, DC-specific FOXO1 KO (CD11c.Cre), ICAM-1/CCR7 rescue transfection, in vivo lymph node homing assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct promoter binding (ChIP), luciferase reporter, genetic KO with rescue; multiple orthogonal methods\",\n      \"pmids\": [\"25786691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CCL19/CCR7 promotes invasion of lung cancer cells by upregulating heparanase via the transcription factor Sp1: CCL19 stimulation increased Sp1 and heparanase expression; CCR7 blockade suppressed Sp1 and heparanase; Sp1 inhibition downregulated heparanase; and ChIP demonstrated Sp1 binding to the heparanase promoter.\",\n      \"method\": \"CCR7 blocking antibody, Sp1 inhibition, ChIP for Sp1 binding to heparanase promoter, RT-PCR, western blot, cell invasion assay\",\n      \"journal\": \"Tumour biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP provides direct promoter binding evidence; multiple inhibitor conditions; single lab\",\n      \"pmids\": [\"23649655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"JAK3 participates in CCR7-mediated DC migration: Jak3-/- bone marrow-derived DCs show impaired chemotactic responses to CCL19 and CCL21 in vitro and in vivo, reduced co-stimulatory molecule expression, and decreased ability to activate T lymphocytes.\",\n      \"method\": \"Jak3 knockout mice, in vitro and in vivo DC migration assays (CCL19/CCL21), contact hypersensitivity assay, lymphocyte proliferation assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with in vivo and in vitro functional readouts; single lab\",\n      \"pmids\": [\"19759904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CCR7 activates PI3Kγ in ALCL tumor cells, providing a survival pathway that confers resistance to ALK tyrosine kinase inhibitors; endothelial cells producing CCL19/CCL21 protect ALCL cells from apoptosis in a CCR7-dependent manner, and genetic CCR7 deletion blocks CNS dissemination and perivascular growth of ALCL in TKI-treated mice.\",\n      \"method\": \"ALCL cell lines and patient-derived xenografts, 3D microfluidic chip with endothelial cells, CCR7 genetic deletion in mouse models, PI3Kγ/δ inhibitor (duvelisib), constitutively active PI3Kγ mouse model\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO and pharmacological inhibition, multiple in vivo and in vitro models, clinical patient data\",\n      \"pmids\": [\"37379367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CCR7 signals through the PI3K/Akt pathway to support DC and cancer cell survival, through MAPK to control chemotaxis, and through RhoA to regulate actin dynamics; these pathways function as biased, largely independent modules for distinct cellular functions.\",\n      \"method\": \"Pathway-specific pharmacological inhibitors, DC functional assays (survival, chemotaxis, endocytosis, actin dynamics), biochemical signaling analysis\",\n      \"journal\": \"Frontiers in pharmacology (review synthesizing primary data)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic data synthesized across multiple primary experiments; pathway dissection supported by pharmacological inhibitors\",\n      \"pmids\": [\"35281921\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CCR7 is a Class A GPCR that couples to Gαi and signals through distinct biased modules—PI3K/Akt (survival), MAPK (chemotaxis), and RhoA/Rho kinase (actin dynamics and motility)—while its two ligands CCL19 and CCL21 elicit differential responses: CCL19 triggers rapid, strong but transient CCR7 internalization and desensitization via β-arrestin/Src endomembrane signaling (forming a Vav1–Rac1 complex that sustains directional migration), whereas CCL21 does not internalize the receptor, permitting persistent surface signaling; N-glycosylation/sialylation of two extracellular residues fine-tunes receptor sensitivity and endocytosis, FOXO1 and EBNA2 transcriptionally regulate CCR7 expression, H3K27me3 epigenetically silences the locus in monocyte-derived DCs, and CCR7 homodimerization enhances ligand binding and downstream Akt/Erk signaling—collectively orchestrating the homing of naïve T cells, regulatory T cells, and dendritic cells to secondary lymphoid organs while also enabling CCR7-expressing cancer cells to metastasize to lymph nodes via CCL19/CCL21 gradients.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CCR7 is a Gαi-coupled chemokine receptor that directs the migration and positioning of T cells, dendritic cells, and other leukocytes to and within secondary lymphoid organs by sensing gradients of its two ligands, CCL19 and CCL21. Signaling proceeds through largely independent downstream modules: PI3K/Akt promotes cell survival, MAPK governs chemotaxis, and RhoA/Rho kinase controls actin dynamics and cell polarization; additionally, CCR7 activates JAK2, ERK5–KLF-2 (upregulating S1P1 for lymph node egress), and HIF-1α (driving glycolytic reprogramming), while internalized CCR7–β-arrestin–Src complexes signal from endomembranes to recruit Vav1 and Rac1, sustaining lamellipodia formation during directed migration [PMID:9498785, PMID:12729902, PMID:12393730, PMID:22334704, PMID:30824325, PMID:31644919, PMID:32351499]. CCL19 induces rapid CCR7 internalization, desensitization, and self-generated chemokine gradient depletion that enables collective long-range guidance, whereas CCL21 does not trigger internalization, permitting persistent surface signaling; receptor function is further tuned by N-glycosylation/sialylation, homodimerization, glycolysis-dependent oligomerization, transcriptional regulation by FOXO1, EBNA2, and Notch1, and epigenetic silencing by H3K27me3 [PMID:11745346, PMID:37656776, PMID:26819318, PMID:28819198, PMID:29941886, PMID:25786691, PMID:7488016, PMID:19536265, PMID:25297875]. Beyond homeostatic lymphocyte homing, CCR7 is co-opted in disease: Notch1-driven CCR7 expression mediates T-ALL infiltration of the CNS, CCR7-dependent PI3Kγ signaling confers resistance to ALK inhibitors in ALCL, and CCR7 on breast cancer cells promotes lymphangiogenesis via AKT-driven VEGF-C secretion [PMID:19536265, PMID:37379367, PMID:25744065].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Before any ligand was known, EBNA2 was shown to transcriptionally activate the orphan receptor EBI1 (later CCR7) in B cells, establishing the gene as an EBV-responsive locus even before its chemokine receptor identity was understood.\",\n      \"evidence\": \"Northern blot with estrogen-inducible EBNA2 system in EBV-negative BL41 B cells\",\n      \"pmids\": [\"7488016\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single inducible system without chromatin-level analysis\", \"no demonstration of direct EBNA2 binding to the CCR7 promoter\", \"functional consequence of EBNA2-induced CCR7 on B cell biology not tested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"The identification of CCL19 as a specific high-affinity ligand for CCR7 deorphanized the receptor and established it as a functional chemokine receptor capable of triggering calcium flux and chemotaxis.\",\n      \"evidence\": \"Alkaline phosphatase-fused ligand binding, calcium mobilization, and chemotaxis assays across multiple transfected receptor lines\",\n      \"pmids\": [\"9153236\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CCL21 not yet identified as a second ligand\", \"G protein coupling not characterized\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Pertussis toxin sensitivity demonstrated that CCR7 signals through Gαi, and CCL19 was shown to induce actin polymerization in primary lymphocytes, linking the receptor to cytoskeletal remodeling.\",\n      \"evidence\": \"Pertussis toxin blockade of chemotaxis, actin polymerization and calcium assays in primary T and B cells\",\n      \"pmids\": [\"9498785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"downstream effectors between Gαi and actin not identified\", \"relative contribution of Gαi vs. Gβγ not resolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The discovery that CCL19 but not CCL21 triggers CCR7 internalization and desensitization revealed a fundamental asymmetry between the two ligands, raising the question of how the same receptor produces distinct cellular outcomes depending on which ligand it engages.\",\n      \"evidence\": \"Flow cytometry-based internalization and functional desensitization assays in T lymphocytes\",\n      \"pmids\": [\"11745346\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"molecular basis for differential internalization (β-arrestin recruitment difference) not yet determined\", \"in vivo significance of differential desensitization unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"JAK2 phosphorylation downstream of CCR7 and inhibition of chemotaxis/integrin activation by JAK inhibitor AG490 revealed a JAK-dependent signaling arm linking CCR7 to lymphocyte adhesion in high endothelial venules in vivo.\",\n      \"evidence\": \"AG490 treatment, intravital microscopy of HEV adhesion, JAK2 phosphorylation western blot in primary lymphocytes\",\n      \"pmids\": [\"12393730\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"which JAK isoform is essential (JAK2 vs. JAK3) not fully resolved\", \"direct physical JAK–CCR7 interaction not shown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Rho kinase was identified as required for CCR7-mediated T cell polarization and chemotaxis, while ERK was dispensable, beginning to dissect signal-specific pathway modules downstream of the receptor.\",\n      \"evidence\": \"Y-27632 (Rho kinase inhibitor) blockade of CCL19/CCL21-induced polarization and migration in T cells\",\n      \"pmids\": [\"12729902\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"pharmacological inhibitor specificity concerns\", \"upstream RhoA activation by CCR7 not directly shown\", \"RhoGEF identity unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"CCR7 knockout mice revealed non-redundant in vivo roles: CCR7 is essential for DC entry into lymphatics and migration to draining lymph nodes, and separately for intrathymic migration of T cell progenitors, establishing CCR7 as a master regulator of immune cell positioning across tissues.\",\n      \"evidence\": \"CCR7-/- mice with flow cytometry, immunohistology, DC trafficking assays, and mixed bone marrow chimeras\",\n      \"pmids\": [\"15308107\", \"15302903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"relative contribution of CCL19 vs. CCL21 in each tissue not resolved\", \"compensatory mechanisms in chronic KO not excluded\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Beyond migration, CCR7 engagement was found to inhibit T cell proliferation and IL-2 secretion via delayed p27Kip1 degradation and CDK1 downregulation, revealing an unexpected anti-proliferative signaling function verified by CCR7-KO T cell hyperproliferation.\",\n      \"evidence\": \"Proliferation assays with soluble/immobilized CCL19/CCL21, CCR7-KO comparison, p27Kip1 and CDK1 western blots\",\n      \"pmids\": [\"17982037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"pathway connecting Gαi to p27Kip1 stabilization not identified\", \"physiological relevance of anti-proliferative signaling in SLOs not tested in vivo\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"In vivo occupancy studies showed that most surface CCR7 on T cells in secondary lymphoid organs is constitutively engaged by CCL19, explaining why transferred T cells have reduced chemokine sensitivity in lymph nodes and demonstrating continuous physiological CCR7 signaling.\",\n      \"evidence\": \"CCR7 occupancy analysis in Ccl19-/- and plt/plt mice with in vitro internalization validation\",\n      \"pmids\": [\"19017956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how continuous engagement affects T cell function beyond desensitization not fully explored\", \"occupancy by CCL21 in vivo not quantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Notch1 was identified as a transcriptional driver of CCR7 in T-ALL, and CCR7/CCL19 signaling was shown to be specifically required for leukemic T cell infiltration of the CNS, linking CCR7 to pathological tissue invasion.\",\n      \"evidence\": \"Gene expression profiling, genetic silencing of CCR7/CCL19 in mouse T-ALL models and human xenografts\",\n      \"pmids\": [\"19536265\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether pharmacological CCR7 blockade is therapeutically viable in CNS leukemia not tested\", \"downstream signaling pathway mediating CNS entry not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"CCR7 was found to control lymphocyte egress from body cavities—not just entry into lymph nodes—as CCR7-deficient mice accumulated T and B cells in peritoneal and pleural spaces, broadening the receptor's role to general lymphocyte recirculation.\",\n      \"evidence\": \"CCR7-KO mice, flow cytometry of peritoneal/pleural lavage, lymphocyte recirculation assays\",\n      \"pmids\": [\"20028772\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"which ligand (CCL19 or CCL21) mediates cavity egress unknown\", \"mechanism of CCR7-dependent egress from serosal surfaces not dissected\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"L-plastin was identified as required for CCR7 polarization to the leading edge and T cell chemotaxis, but dispensable for CCR7-triggered F-actin polymerization, separating receptor signaling from spatial receptor redistribution during migration.\",\n      \"evidence\": \"LPL-/- mice, two-photon microscopy in lymph nodes, receptor localization imaging, thymic egress assays\",\n      \"pmids\": [\"20194718\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct LPL–CCR7 physical interaction not demonstrated\", \"mechanism linking LPL to CCR7 membrane clustering unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"CCR7/CCL19 was found to upregulate S1P receptor 1 (S1P1) expression via an ERK5→KLF-2 axis, revealing a cross-talk mechanism whereby CCR7 primes T cells for subsequent S1P1-dependent lymph node egress.\",\n      \"evidence\": \"ERK5-flox/Lck-Cre conditional KO, migration assays to S1P, western blot for pathway components\",\n      \"pmids\": [\"22334704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether CCL21 activates the same ERK5–KLF-2 axis not tested\", \"in vivo validation of CCR7-dependent S1P1 upregulation for LN egress not shown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Epigenetic profiling revealed that H3K27me3 silences the Ccr7 locus specifically in monocyte-derived DCs but not conventional DCs, explaining lineage-specific CCR7 expression and migratory capacity differences between DC subsets.\",\n      \"evidence\": \"ChIP-seq/ChIP-PCR for H3K27me3 in bone marrow-derived and lung DC subsets, monocyte differentiation time-course\",\n      \"pmids\": [\"25297875\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"identity of the histone methyltransferase responsible not determined\", \"whether H3K27me3 removal can rescue moDC migration not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Multiple advances refined CCR7 regulation: FOXO1 was shown to directly bind and activate the CCR7 promoter in DCs (controlling in vivo LN homing), N-glycosylation/sialylation of two extracellular residues was found to dampen CCR7 signaling and endocytosis, and NMR mapping revealed overlapping CCR7/PSGL-1 binding sites on CCL19.\",\n      \"evidence\": \"ChIP and luciferase reporter for FOXO1, DC-specific FOXO1-KO with rescue; mutagenesis of glycosylation sites with functional assays; NMR structure of CCL19 with chemical shift perturbation\",\n      \"pmids\": [\"25786691\", \"26819318\", \"26115234\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether FOXO1 and epigenetic (H3K27me3) regulation are coordinated is unknown\", \"structural basis of glycosylation effects on receptor conformation not resolved\", \"functional consequence of PSGL-1/CCR7 competition for CCL19 in vivo not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"CCR7 homodimerization was shown to enhance ligand binding, migration, and Akt/Erk signaling, as demonstrated by a synthetic peptide that disrupted dimers and attenuated all CCR7 functions, establishing oligomeric state as a regulatory mechanism.\",\n      \"evidence\": \"Bidirectional dimer induction/disruption with synthetic peptide, migration, binding, internalization, and signaling assays\",\n      \"pmids\": [\"28819198\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"structural basis of CCR7 dimer interface not determined\", \"stoichiometry of active signaling complex unknown\", \"in vivo relevance of dimerization not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Glycolytic metabolism was linked to CCR7 function: early glycolysis induction supports CCR7 oligomerization and DC motility, and PI3K/Akt, MAPK, and RhoA were confirmed as biased, largely independent signaling modules controlling survival, chemotaxis, and actin dynamics, respectively.\",\n      \"evidence\": \"Glycolysis inhibition (2-DG) with CCR7 oligomerization and DC migration assays; pathway-specific pharmacological dissection of DC functions\",\n      \"pmids\": [\"29941886\", \"35281921\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how glycolysis mechanistically promotes CCR7 oligomerization not resolved\", \"whether metabolic requirement is specific to CCR7 or general for GPCRs not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Two major mechanistic advances defined endosomal and metabolic signaling: internalized CCR7/β-arrestin/Src complexes recruit Vav1–Rac1 at endomembranes to sustain lamellipodia formation; separately, CCR7 activates HIF-1α-driven glycolysis in DCs, with the lncRNA lnc-Dpf3 providing negative feedback by binding HIF-1α and suppressing Ldha transcription.\",\n      \"evidence\": \"Co-IP, proximity ligation, Rac1 photoactivation at endomembranes; DC-specific lnc-Dpf3 KO, RNA pull-down, m6A analysis, metabolic assays, in vivo DC migration\",\n      \"pmids\": [\"31644919\", \"30824325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether endomembrane signaling occurs with CCL21 (which poorly internalizes CCR7) not addressed\", \"generality of lnc-Dpf3 feedback beyond DCs unknown\", \"structural basis of Src phosphorylation site on CCR7 not mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Systematic BRET assays comparing CCL19 and CCL21 in a uniform background found both ligands activate G proteins and recruit β-arrestin, with CCL19 showing higher potency but no clear qualitative bias, challenging earlier models of strict ligand-biased agonism.\",\n      \"evidence\": \"BRET-based G protein and β-arrestin recruitment assays in defined cellular system\",\n      \"pmids\": [\"33921794\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"apparent conflict with in vivo differential internalization data not fully reconciled\", \"assays in overexpression system may not recapitulate endogenous receptor density\", \"lack of measurement of downstream effector bias (e.g., Akt vs. Erk)\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"CCR7's role extended to neutrophils: microbially stimulated neutrophils upregulate CCR7 and migrate to draining lymph nodes via lymphatics, where they are phagocytosed by DCs; separately, ACKR4 on lymphatic collector endothelium was identified as a scavenger of CCL19/CCL21 that shapes the chemotactic field enabling T cell transit.\",\n      \"evidence\": \"Neutrophil-specific CCR7-deficient chimeras, photoconvertible mouse tracking, S. aureus models; ACKR4-KO mice with intravital microscopy and flow-induced gene expression analysis\",\n      \"pmids\": [\"35119939\", \"35108538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"signaling pathway in neutrophils vs. T cells/DCs not compared\", \"whether ACKR4 shapes gradients for neutrophil migration as well is unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"CCR7's role as both sensor and sink for CCL19 was demonstrated: ligand-induced internalization depletes local CCL19, creating self-generated gradients that drive collective DC migration and long-range guidance; in cancer, CCR7-PI3Kγ signaling was shown to confer ALK-inhibitor resistance and CNS dissemination in ALCL.\",\n      \"evidence\": \"Chemotaxis assays with mathematical modeling and gradient visualization; ALCL patient-derived xenografts, CCR7 genetic deletion, PI3Kγ/δ inhibitor duvelisib, constitutively active PI3Kγ model\",\n      \"pmids\": [\"37656776\", \"37379367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"self-generated gradient mechanism not validated for CCL21\", \"whether PI3Kγ dependence applies broadly to CCR7-driven cancers beyond ALCL is untested\", \"structural basis of CCR7–PI3Kγ coupling not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of CCR7 homodimerization and ligand-selective internalization, the full phosphorylation code on CCR7's C-terminus that differentiates β-arrestin vs. G-protein outcomes, and whether therapeutic CCR7 antagonism can selectively block pathological (cancer/leukemia) migration without disrupting homeostatic immune cell trafficking.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"no high-resolution structure of CCR7 in complex with either ligand\", \"phosphosite-specific mutagenesis linking C-tail phosphorylation to distinct signaling arms not performed\", \"selective therapeutic targeting strategy not demonstrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 3, 23]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [8, 14, 32]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 15, 18, 19]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 4, 5, 14, 18, 21, 23, 31, 32]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 7, 9, 11, 24, 25, 26]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [19, 20]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [10, 17, 22, 29, 31]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 27, 28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CCL19\",\n      \"CCL21\",\n      \"ARRB1\",\n      \"SRC\",\n      \"VAV1\",\n      \"RAC1\",\n      \"FOXO1\",\n      \"ACKR4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}